PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	C-X-C motif chemokine ligand 8	Homo sapiens	82-95
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	C-X-C motif chemokine ligand 8	Homo sapiens	97-101
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	interleukin 10	Homo sapiens	104-109
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	plasminogen activator, urokinase	Homo sapiens	111-147
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	plasminogen activator, urokinase	Homo sapiens	149-152
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	matrix metallopeptidase 9	Homo sapiens	155-182
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	matrix metallopeptidase 9	Homo sapiens	184-189
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	tumor necrosis factor	Homo sapiens	196-223
34445558-11	2021	The conditioned medium obtained from IronQ-treated PBMCs contained high levels of interleukin 8 (IL-8), IL-10, urokinase-type-plasminogen-activator (uPA), matrix metalloproteinases-9 (MMP-9), and tumor necrosis factor-alpha (TNF-alpha), as well as augmented migration and capillary network formation of HUVECs and fibroblast cells, in vitro.	ironq	37-42	tumor necrosis factor	Homo sapiens	225-234